Skip to main content

IMMUTEP Ltd

IMMP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001506184

No open-market purchases or sales by IMMUTEP Ltd insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $692.0K in total; no superinvestor holds it.

Other share classesPRRUF

Q4 2022 vs. Q3 2022

How the institutions holding IMMUTEP Ltd changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of IMMP: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders2125+4
Shares5.33M4.14M−1.19M (−22.2%)
Value$8.31M$7.25M−$1.06M (−12.8%)

New holders (7)

Institutions that held IMMUTEP Ltd at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to IMMP in Q4 2022
InstitutionSharesValue% of portfolio
Jane Street Group, LLC21,785$38.1K0.00%
Old Mission Capital LLC21,158$37.0K0.00%
Virtu Financial LLC11,926$21.0K0.00%
HighTower Advisors, LLC10,000$18.0K0.00%
Belpointe Asset Management LLC3,000$5.25K0.00%
BNP Paribas Arbitrage, SA700$1.23K0.00%
Royal Bank of Canada16$00.00%

Sold out (3)

Institutions that held IMMUTEP Ltd at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of IMMP in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
BlackRock Inc.517,096$807.0K
Balyasny Asset Management LLC35,173$55.0K
Pittenger & Anderson Inc500$1.00K